Ryali Sriram
CIK: 0001762893•Chief Financial Officer
Officer
Primary company: Eiger BioPharmaceuticals, Inc. (EIGR)
Ryali Sriram is a corporate insider (Chief Financial Officer) at Eiger BioPharmaceuticals, Inc. (EIGR) filing SEC Form 4 transactions. 19 transactions across 3 companies, totaling $58,360 in purchases and $12,683 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 247,500 | $1.80 | $446K | 247,500 | 2/20/2026 Filed: 2/20/2026 | Filing → | |
| Award | 55,000 | - | - | 72,360 | 2/20/2026 Filed: 2/20/2026 | Filing → | |
| Purchase | 17,360 | $1.42 | $25K | 17,360 | 1/29/2025 Filed: 1/30/2025 | Filing → | |
| Award | 300,000 | $1.64 | $492K | 300,000 | 1/10/2025 Filed: 1/10/2025 | Filing → | |
CODEXIS, INC. CDXS | Award | 314,125 | - | - | 314,125 | 1/1/2024 Filed: 1/2/2024 | Filing → |
CODEXIS, INC. CDXS | Award | 52,350 | - | - | 175,791 | 1/1/2024 Filed: 1/2/2024 | Filing → |
CODEXIS, INC. CDXS | Purchase | 11,650 | $1.70 | $20K | 123,441 | 9/8/2023 Filed: 9/12/2023 | Filing → |
CODEXIS, INC. CDXS | Award | 372,637 | $0.00 | $0 | 372,637 | 2/10/2023 Filed: 2/14/2023 | Filing → |
CODEXIS, INC. CDXS | Award | 111,791 | $0.00 | $0 | 111,791 | 2/10/2023 Filed: 2/14/2023 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Sale | 2,266 | $5.60 | $13K | 41,566 | 3/14/2022 Filed: 3/14/2022 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 143,000 | $0.00 | $0 | 143,000 | 3/11/2022 Filed: 3/11/2022 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 24,000 | $0.00 | $0 | 43,832 | 3/11/2022 Filed: 3/11/2022 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 30,000 | $0.00 | $0 | 30,000 | 7/29/2021 Filed: 7/30/2021 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 87,000 | $0.00 | $0 | 87,000 | 5/10/2021 Filed: 5/11/2021 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 97,500 | $0.00 | $0 | 97,500 | 3/12/2021 Filed: 3/15/2021 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 16,250 | $0.00 | $0 | 18,152 | 3/12/2021 Filed: 3/15/2021 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 65,000 | $0.00 | $0 | 65,000 | 3/12/2020 Filed: 3/13/2020 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 229 | $7.31 | $2K | 1,628 | 3/5/2020 Filed: 3/13/2020 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Award | 149 | $9.37 | $1K | 1,399 | 9/5/2019 Filed: 9/6/2019 | Filing → |
Eiger BioPharmaceuticals, Inc. EIGR | Purchase | 1,250 | $11.08 | $14K | 1,250 | 4/22/2019 Filed: 4/22/2019 | Filing → |
Type
Award
Shares
247,500
Price
$1.80
Value
$446K
Type
Award
Shares
55,000
Price
-
Value
-
Type
Purchase
Shares
17,360
Price
$1.42
Value
$25K
Type
Award
Shares
300,000
Price
$1.64
Value
$492K
CODEXIS, INC.
CDXS
Type
Award
Shares
314,125
Price
-
Value
-
CODEXIS, INC.
CDXS
Type
Award
Shares
52,350
Price
-
Value
-
CODEXIS, INC.
CDXS
Type
Purchase
Shares
11,650
Price
$1.70
Value
$20K
CODEXIS, INC.
CDXS
Type
Award
Shares
372,637
Price
$0.00
Value
$0
CODEXIS, INC.
CDXS
Type
Award
Shares
111,791
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Sale
Shares
2,266
Price
$5.60
Value
$13K
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
143,000
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
24,000
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
30,000
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
87,000
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
97,500
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
16,250
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
65,000
Price
$0.00
Value
$0
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
229
Price
$7.31
Value
$2K
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Award
Shares
149
Price
$9.37
Value
$1K
Eiger BioPharmaceuticals, Inc.
EIGR
Type
Purchase
Shares
1,250
Price
$11.08
Value
$14K
AI Agent
Try asking...